Bangladesh vs Congo: Access to anti-retroviral drugs, female
Bangladesh
33.0%
in 2024
Congo
33.0%
in 2024
Bangladesh rank
133rd
Congo rank
133rd
Access to anti-retroviral drugs, female over time
- Bangladesh
- Congo
How they compare
Bangladesh currently reports 33.0% against 33.0% in Congo, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Congo ahead.
Bangladesh ranks 133rd and Congo ranks 133rd of 141 countries.
Across the 3 decades both report, Bangladesh averaged higher in 1 and Congo in 2.
Head to head by decade
| Decade | Bangladesh | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 3.1% | 1.4% | Congo |
| 2010s | 16.0% | 21.0% | 5.0% | Congo |
| 2020s | 30.0% | 28.2% | 1.8% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bangladesh or Congo?
- Bangladesh, at 33.0% against 33.0% in Congo as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bangladesh and Congo?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Congo?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Congo rank globally for access to anti-retroviral drugs, female?
- Bangladesh ranks 133rd and Congo ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.